Biomarin Pharmaceutical Inc. - Registered Shares
NASDAQ:BMRN 3:59:50 PM EDT
| Market Cap (Intraday) | 14.02B |
| Current PE | 16.31 |
| Forward PE | N/A |
| 2yr Forward PE | 72.72 |
| 10-Day MA | $77.27 |
| 50-Day MA | $79.78 |
| 200-Day MA | $87.86 |
BioMarin Pharmaceutical, Inc. Stock, NASDAQ:BMRN
770 Lindaro Street, San Rafael, California 94901
United States of America
Phone: +1.415.506.6700
Number of Employees: 3001
Description
BioMarin Pharmaceutical, Inc. is a biotechnology company, which engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline include Vosoritide (BMN 111) for Achondroplasia and Valoctocogene Roxaparvovec (BMN 270) for Hemophilia A. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997 and is headquartered in San Rafael, CA.